Kaiser Poll Show Support for Personal Imporatation

Kaiser Poll Show Support for Personal Imporatation

Monday, August 29, 2016

Mylan, PhRMA 'play' Congress and the American Public

by Daniel Hines
Publisher, RxforAmericanHealth

Even before reading this article,  I suggested that perhaps Mylan was implementing a ‘play’ upon the American pubic…first with the price increases, then with the  rapid price decreases, and now the move with a ‘new generic’ ...seems to me to be actions designed to allow Mylan to take the steps necessary to enter the market with a ‘generic’ and Teva must wait until 2017 with approval and a new review,  by which time Mylan will control the generic segment of this market. While the introduction of the generic is not included in this story, the article deals with the PhRMA PR campaign and mind-set of an industry that has ‘played’ the American Public and Congress for decades...

Post a Comment